Dyskinesia Drug-induced
📧 Sign up to get email alerts when something new happens for Dyskinesia Drug-induced.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy [Phase 2, Phase 3]
A Phase 2/3 trial of dipraglurant (ADX48621) in Parkinson disease patients on levodopa-based therapy has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors
A completed clinical trial examining whether HMG-CoA reductase inhibitors (statins) can prevent levodopa-induced dyskinesia in Parkinson dis…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias [Phase 2]
Open-label Phase 2 trial assessing AFQ056 for safety, tolerability, and efficacy in Parkinson's patients with L-dopa induced dyskinesias com…
-
CLINICAL_TRIALS withdrawal · 2020-06-17Clinical Trial Update: Safinamide for Levodopa-induced Dyskinesia (PD-LID) [Phase 3]
Phase 3 clinical trial for safinamide in Parkinson disease with levodopa-induced dyskinesia has been withdrawn.